SNDL Posts C$50.8M Q3 Loss on C$52.0M Goodwill Impairment
SNDL is trading near its 52-week low of $1.13 (12% above the low).
Summary
SNDL posted a C$50.8M Q3 2026 net loss, almost entirely a C$52.0M non-cash goodwill impairment in cannabis operations, while adjusted operating income turned positive at C$5.2M and free cash flow rose to C$20.0M; total revenue fell 2.5% to C$238M and the operating loss widened to C$48.3M from C$11.1M.
Updated with a Dow Jones Newswires report · What changed
Updates
· Dow Jones Newswires — SNDL's Q3 revenue fell 2.5% to C$238M, with cannabis-operations revenue down 28% and liquor-retail revenue down 3.3%.
- Operating loss widened to C$48.3M from C$11.1M a year earlier.
- Cannabis-retail revenue edged up 0.7%.
Key Events · Earnings and Guidance · SNDL
-
New · · Dow Jones Newswires
Q3 Revenue Falls 2.5% to C$238M
Total Q3 revenue fell 2.5% to C$238M, with cannabis-operations revenue down 28% and liquor-retail revenue down 3.3%, while cannabis-retail revenue edged up 0.7%. The operating loss widened to C$48.3M from C$11.1M a year earlier.
-
C$52.0M Goodwill Impairment Drives Loss
A C$52.0M impairment to cannabis operations manufacturing goodwill pushed the Q3 2026 net loss to C$50.8M (C$0.21 per share), versus C$13.3M (C$0.05) a year earlier.
-
Adjusted Operating Income Turns Positive
Excluding the impairment and restructuring, adjusted operating income was C$5.2M versus a C$9.5M loss in Q3 2025, and free cash flow rose to C$20.0M from C$16.7M.
-
Cannabis Operations Gross Profit Negative
Cannabis operations revenue fell to C$27.0M from C$37.4M on lower provincial-board and wholesale sales, pushing segment gross profit to -C$1.6M (-6.0% margin) from C$5.0M (13.4%).
-
Cash Falls on SunStream and Buybacks
Cash and equivalents dropped to C$132.5M from C$252.2M at December 31, 2025, after a C$60.8M capital contribution to SunStream and C$43.1M of share repurchases in the nine months.
Analysis · SNDL · Life Sciences
The headline loss reflects an accounting charge rather than cash burn: C$52.0M of the C$50.8M net loss is a non-cash goodwill write-down on the cannabis manufacturing unit, which management says is running below forecast. Excluding that item, adjusted operating income was C$5.2M versus a C$9.5M loss a year ago, and free cash flow rose to C$20.0M from C$16.7M. The operating loss still widened to C$48.3M from C$11.1M as total revenue fell 2.5% to C$238M. Operational pressure points are more telling: cannabis operations gross profit went negative (-C$1.6M, -6.0% margin) as provincial-board and wholesale sales fell and cannabis-operations revenue dropped 28%, while liquor retail revenue slipped 3.3% on lower traffic and cannabis-retail revenue edged up 0.7%. Cash dropped to C$132.5M from C$252.2M at year-end, mostly because C$60.8M went into SunStream and C$43.1M into buybacks. That buyback pace is the thing to weigh against the impairment — the company is shrinking its share count while writing down the value of its production assets.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNDL was trading at $1.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $312.6M. The 52-week trading range was $1.13 to $2.34. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.